| WHO-EORTC classification for cutaneous lymphomas R Willemze, ES Jaffe, G Burg, L Cerroni, E Berti, SH Swerdlow, ... Blood 105 (10), 3768-3785, 2005 | 4882 | 2005 |
| Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases R Willemze, PM Jansen, L Cerroni, E Berti, M Santucci, C Assaf, ... Blood, The Journal of the American Society of Hematology 111 (2), 838-845, 2008 | 740 | 2008 |
| Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial YH Kim, M Bagot, L Pinter-Brown, AH Rook, P Porcu, SM Horwitz, ... The lancet oncology 19 (9), 1192-1204, 2018 | 543 | 2018 |
| European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome–Update 2017 F Trautinger, J Eder, C Assaf, M Bagot, A Cozzio, R Dummer, R Gniadecki, ... European journal of cancer 77, 57-74, 2017 | 526 | 2017 |
| Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas: a distinct clinicopathological entity with an aggressive clinical behavior E Berti, D Tomasini, MH Vermeer, CJLM Meijer, E Alessi, R Willemze The American journal of pathology 155 (2), 483-492, 1999 | 517 | 1999 |
| European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell … NJ Senff, EM Noordijk, YH Kim, M Bagot, E Berti, L Cerroni, R Dummer, ... Blood, The Journal of the American Society of Hematology 112 (5), 1600-1609, 2008 | 503 | 2008 |
| EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary … W Kempf, K Pfaltz, MH Vermeer, A Cozzio, PL Ortiz-Romero, M Bagot, ... Blood, The Journal of the American Society of Hematology 118 (15), 4024-4035, 2011 | 470 | 2011 |
| WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects G Burg, W Kempf, A Cozzio, J Feit, R Willemze, E S. Jaffe, R Dummer, ... Journal of cutaneous pathology 32 (10), 647-674, 2005 | 438 | 2005 |
| Cutaneous Lymphoma International Consortium study of outcome in advanced stages of mycosis fungoides and Sézary syndrome: effect of specific prognostic markers on survival and … JJ Scarisbrick, HM Prince, MH Vermeer, P Quaglino, S Horwitz, P Porcu, ... Journal of Clinical Oncology 33 (32), 3766, 2015 | 429 | 2015 |
| The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome AC da Silva Almeida, F Abate, H Khiabanian, E Martinez-Escala, J Guitart, ... Nature genetics 47 (12), 1465-1470, 2015 | 392 | 2015 |
| Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO–EORTC classification for cutaneous lymphomas: comparison with previous classifications and … NJ Senff, JJ Hoefnagel, PM Jansen, MH Vermeer, J van Baarlen, ... Journal of clinical oncology 25 (12), 1581-1587, 2007 | 332 | 2007 |
| Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling JJ Hoefnagel, R Dijkman, K Basso, PM Jansen, C Hallermann, ... Blood 105 (9), 3671-3678, 2005 | 320 | 2005 |
| Primary cutaneous large B-cell lymphomas of the legs: a distinct type of cutaneous B-cell lymphoma with an intermediate prognosis MH Vermeer, FAMJ Geelen, CW van Haselen, PC van Voorst Vader, ... Archives of dermatology 132 (11), 1304-1308, 1996 | 307 | 1996 |
| Epigenetic Profiling of Cutaneous T-Cell Lymphoma: Promoter Hypermethylation of Multiple Tumor Suppressor Genes Including BCL7a, PTPRG, and p73 R Van Doorn, WH Zoutman, R Dijkman, RX De Menezes, S Commandeur, ... Journal of Clinical Oncology 23 (17), 3886-3896, 2005 | 288 | 2005 |
| Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients MW Bekkenk, MH Vermeer, PM Jansen, AMW van Marion, ... Blood 102 (6), 2213-2219, 2003 | 277 | 2003 |
| Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases MF Benner, PM Jansen, MH Vermeer, R Willemze Blood, The Journal of the American Society of Hematology 119 (7), 1643-1649, 2012 | 243 | 2012 |
| Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome R van Doorn, MS van Kester, R Dijkman, MH Vermeer, AA Mulder, ... Blood, The Journal of the American Society of Hematology 113 (1), 127-136, 2009 | 236 | 2009 |
| Novel and highly recurrent chromosomal alterations in Sezary syndrome MH Vermeer, R van Doorn, R Dijkman, X Mao, S Whittaker, ... Cancer research 68 (8), 2689-2698, 2008 | 234 | 2008 |
| Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis R van Doorn, R Dijkman, MH Vermeer, JJ Out-Luiting, ... Cancer research 64 (16), 5578-5586, 2004 | 203 | 2004 |
| The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients JJ Scarisbrick, P Quaglino, HM Prince, E Papadavid, E Hodak, M Bagot, ... British Journal of Dermatology 181 (2), 350-357, 2019 | 187 | 2019 |
